| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2333 | Fluvastatin sodium, Amorphous-2 | BIOCON LIMITED Bengaluru IN | 100011487;100018595 | CEP 2022-139 - Rev 02 | 2025/09/22 | Valid | 22/07/2027 | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Administrative procedure|CEP granted|08/08/2022; New application|CEP granted|22/07/2022 |
|
| 798 | Fusidic acid, Process B | FUJIAN COMHONY BIOTECHNOLOGY CO., LTD. Fuqing CN | 100043888;100072481 | CEP 2022-330 - Rev 02 | 2025/09/22 | Valid | 28/04/2028 | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Minor revision|CEP granted|15/10/2024; New application|CEP granted|28/04/2023 |
|
| 848 | Sodium fusidate, Process B | FUJIAN COMHONY BIOTECHNOLOGY CO., LTD. Fuqing CN | 100043888;100072481 | CEP 2022-369 - Rev 02 | 2025/09/22 | Valid | 28/04/2028 | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Minor revision|CEP granted|04/11/2024; New application|CEP granted|28/04/2023 |
|
| 2191 | Atorvastatin calcium, Process 4, polymorphic form-I | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2024-238 - Rev 02 | 2025/09/22 | Valid | 04/10/2029 | Chemical | 2025/09/22 | Major revision|CEP granted|22/09/2025; Notification|CEP granted|26/05/2025; New application|CEP granted|07/10/2024 |
|
| 1472 | Sodium hyaluronate, Intrinsic viscosity 1.55 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use | AMHWA BIOPHARM CO., LTD. Binzhou CN | 100054851;100097324 | CEP 2018-285 - Rev 02 | 2025/09/19 | Valid | Chemical | 2025/09/19 | Renewal|CEP granted|19/09/2025; Notification|CEP granted|21/06/2022 |
||
| 2737 | Zolmitriptan | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2020-422 - Rev 03 | 2025/09/19 | Valid | 18/05/2027 | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Notification|CEP granted|15/07/2024; Minor revision|CEP granted|13/10/2023; Minor revision|Accepted - CEP remains valid|03/08/2023; New application|CEP granted|18/05/2022 |
|
| 2465 | Irbesartan, Process II | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2021-100 - Rev 04 | 2025/09/19 | Valid | 27/09/2026 | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Minor revision|Accepted - CEP remains valid|16/12/2024; Notification|CEP granted|19/07/2024; Minor revision|CEP granted|28/04/2023; Minor revision|CEP granted|12/07/2022; New application|CEP granted|27/09/2021 |
|
| 2585 | Rizatriptan benzoate | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2011-299 - Rev 04 | 2025/09/19 | Valid | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Notification|CEP granted|15/07/2024 |
||
| 2103 | Propafenone hydrochloride | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2008-100 - Rev 05 | 2025/09/19 | Valid | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Notification|CEP granted|11/07/2024; Minor revision|Accepted - CEP remains valid|09/10/2020 |
||
| 1084 | Cetirizine dihydrochloride | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2000-031 - Rev 13 | 2025/09/19 | Valid | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Notification|CEP granted|19/07/2024; Minor revision|Accepted - CEP remains valid|29/04/2024; Minor revision|CEP granted|09/03/2022 |
||
| 2601 | Pioglitazone hydrochloride | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2012-315 - Rev 02 | 2025/09/19 | Valid | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Notification|CEP granted|11/07/2024; Minor revision|Accepted - CEP remains valid|01/06/2021 |
||
| 2465 | Irbesartan | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2010-124 - Rev 09 | 2025/09/19 | Valid | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Minor revision|Accepted - CEP remains valid|19/12/2024; Notification|CEP granted|19/07/2024; Minor revision|CEP granted|26/04/2023; Major revision|CEP granted|26/07/2022; Major revision|CEP granted|10/06/2021 |
||
| 1756 | Lamotrigine | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2009-157 - Rev 03 | 2025/09/19 | Valid | Chemical | 2025/09/19 | Notification|CEP granted|19/09/2025; Notification|CEP granted|12/07/2024 |
||
| 931 | Metformin Hydrochloride | APITORIA PHARMA PRIVATE LIMITED Hyderabad IN | 100049668;100086364 | CEP 2004-088 - Rev 10 | 2025/09/18 | Valid | Chemical | 2025/09/18 | Minor revision|CEP granted|18/09/2025; Minor revision|CEP granted|21/11/2024; Notification|CEP granted|13/12/2023; Minor revision|CEP granted|02/03/2021 |
||
| 2018 | Paroxetine hydrochloride hemihydrate | APITORIA PHARMA PRIVATE LIMITED Hyderabad IN | 100049668;100086364 | CEP 2006-206 - Rev 05 | 2025/09/18 | Valid | Chemical | 2025/09/18 | Minor revision|CEP granted|18/09/2025; Minor revision|Accepted - CEP remains valid|15/10/2024; Notification|CEP granted|13/12/2023; Minor revision|CEP granted|26/01/2023; Minor revision|Accepted - CEP remains valid|13/07/2022; Notification|Accepted - CEP remains valid|06/11/2020 |
||
| 2617 | Aripiprazole | ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL | 100000470;100001572 | CEP 2013-230 - Rev 03 | 2025/09/18 | Valid | Chemical | 2025/09/18 | Minor revision|CEP granted|18/09/2025; Minor revision|CEP granted|17/03/2023; Monograph revision|CEP granted|16/07/2021; Renewal|CEP granted|11/06/2020 |
||
| 334 | Hydrocortisone acetate, Micronised, Grades I and II | SYMBIOTEC PHARMALAB PRIVATE LIMITED Indore IN | 100018972;100095999 | CEP 2016-228 - Rev 03 | 2025/09/18 | Valid | Chemical | 2025/09/18 | Minor revision|CEP granted|18/09/2025; Renewal|CEP granted|27/10/2023; Minor revision|CEP granted|16/09/2022 |
||
| 1287 | Alfuzosin hydrochloride | APITORIA PHARMA PRIVATE LIMITED Hyderabad IN | 100049668;100086364 | CEP 2007-080 - Rev 04 | 2025/09/18 | Valid | Chemical | 2025/09/18 | Minor revision|CEP granted|18/09/2025; Minor revision|Accepted - CEP remains valid|29/08/2024; Notification|CEP granted|16/11/2023; Notification|Accepted - CEP remains valid|15/07/2021; Minor revision|Accepted - CEP remains valid|08/09/2020 |
||
| 2409 | Diacerein | AMI LIFESCIENCES PRIVATE LIMITED Vadodara IN | 100021822;100030527 | CEP 2015-173 - Rev 04 | 2025/09/18 | Valid | Chemical | 2025/10/17 | Minor revision|Accepted - CEP remains valid|17/10/2025; Minor revision|CEP granted|18/09/2025; Minor revision|CEP granted|03/12/2024; Minor revision|Accepted - CEP remains valid|28/11/2022; Administrative procedure|CEP granted|04/04/2022; Notification|CEP granted|18/01/2022; Renewal|CEP granted|17/11/2021 |
||
| 2751 | Valaciclovir hydrochloride hydrate | APITORIA PHARMA PRIVATE LIMITED Hyderabad IN | 100049668;100086364 | CEP 2013-318 - Rev 03 | 2025/09/18 | Valid | Chemical | 2025/09/18 | Minor revision|CEP granted|18/09/2025; Notification|CEP granted|02/02/2024; Major revision|CEP granted|22/08/2022 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号